Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
AGMT_MM-1: Assessing the oral microbiome in patients with relapsed/refractory mu...
Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria
Investigating KRd versus KTd in NDMM patients with high-risk cytogenetics
Prof Heinz Ludwig - Wilhelmeninen Cancer Research Institute, Vienna, Austria
GMMG-CONCEPT: Isa-KRd in front-line treatment of high-risk myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
CANDOR trial design: Investigating KdD versus Kd in relapsed/refractory multiple...
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
CANDOR updated results: KdD versus Kd in patients with RRMM according to prior l...
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
Patient reported outcomes for the CANDOR trial for multiple myeloma
Prof Katja Weisel - University Medical Center Hamburg-Eppendorf, Hamburg, German...
CTC count as a prognostic marker for androgen deprivation plus orteronel or bica...
Dr Amir Goldkorn - Keck School of Medicine of USC, Los Angeles, USA
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in...
Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurre...
Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based thera...
Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma
Dr Katie Kelley - University of California San Francisco, San Francisco, USA
COVID-19 and breast cancer: How should we treat our patients?
Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain